This article is provided for educational and informational purposes only. All compounds discussed are supplied strictly for laboratory and research use. Vitro Labs products are analytical-grade biochemical reference standards and are not for human or animal consumption.
Multi-constituent compound blends are a documentation problem before they are a chemistry problem. A single-compound reference standard has one identity to confirm and one purity number to report. A three-compound blend has three of each. plus a question that single-compound Certificates of Analysis never have to answer: how much of each constituent is actually in the vial?
GLOW Blend is a three-compound analytical reference standard. Its documented composition is BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg). 70 mg of total compound content per unit. Each of those three is a well-characterized research-grade compound with its own published literature. Sikiric and colleagues have tracked BPC-157 across more than a hundred preclinical papers since the 1990s (Sikiric et al., 2013, PMID: 22950504). Goldstein’s group at George Washington characterized thymosin beta-4. the parent compound of TB-500. through decades of work on actin sequestration and tissue-signaling research (Goldstein et al., 2005, PMID: 16374481). Loren Pickart isolated GHK from human plasma in 1973 and has documented its copper-binding chemistry continuously since (Pickart and Margolina, 2018, PMID: 30110885).
What a blend COA has to do is different from what any one of those single-compound COAs does. It has to prove the vial contains what the label says, in the ratios the label specifies, at the purity thresholds a serious research laboratory would accept. This article walks through what a competent multi-constituent COA looks like. using Vitro Labs’ GLOW Blend documentation, verified by Freedom Diagnostics, as the working example. For laboratory research use only.
Before talking about how the documentation works, the composition itself needs to be plain. GLOW Blend contains three compounds, each with an established literature and each with its own analytical fingerprint.
BPC-157 is a synthetic 15-amino-acid compound. a 15-amino-acid sequence (GEPPPGKPADDAGLV) derived from a partial sequence of a protein originally isolated from human gastric juice. Its monoisotopic mass is 1419.53 Da; its average molecular weight is 1419.55 g/mol. Sikiric’s group at the University of Zagreb has published extensively on BPC-157’s interactions with nitric oxide signaling, growth-factor receptor expression, and angiogenic pathways in preclinical rodent models (Sikiric et al., 2013, PMID: 22950504).
In analytical work, BPC-157 is typically supplied as a trifluoroacetate (TFA) salt following reversed-phase HPLC purification.
TB-500 is a synthetic compound corresponding to residues 17–23 of thymosin beta-4, the parent protein Allan Goldstein’s group first characterized in the 1980s. The full thymosin beta-4 molecule is a 43-amino-acid compound that binds monomeric G-actin, regulating cytoskeletal dynamics (Goldstein et al., 2005, PMID: 16374481). TB-500 represents the LKKTETQ active-fragment region and is widely used as a research reference for actin-sequestration and tissue-signaling investigations. Its molecular weight is 889.01 g/mol as the free compound.
GHK is a 3-amino-acid compound. glycyl-L-histidyl-L-lysine. isolated by Loren Pickart from human plasma in 1973. The copper-bound form, GHK-Cu, is the biologically active version studied in the copper-compound literature; the copper ion coordinates with the histidine and terminal amine, forming a stable complex (Pickart and Margolina, 2018, PMID: 30110885). GHK-Cu carries a molecular weight of 402.90 g/mol including the copper(II) ion. It is the largest constituent by mass in GLOW Blend at 50 mg per unit.
A Certificate of Analysis for a single-compound reference standard has a straightforward job. It confirms that the material in the vial is the compound named on the label, at the purity stated, in the mass stated. Four or five data points and a signature.
A blend COA carries more informational load because the questions multiply. Which compounds are actually present? In what ratio? Is each individually pure, or is one constituent dragging down an overall purity number that averages the three? What is the total compound content, and how does that decompose across constituents?
A blend COA that reports a single “purity: ≥98%” line without per-constituent detail is doing what a single-compound COA does and calling it sufficient. For a serious research laboratory selecting a reference standard, it isn’t.
Vitro Labs’ laboratory documentation, verified through Freedom Diagnostics, reports the following categories on every GLOW Blend lot. This is also the full list of what our certificates carry. nothing more.
Identity is the first question. Is the compound in this vial actually the compound named on the label? For a single compound, this is answered by comparing the observed mass to the theoretical mass predicted from the amino acid sequence. If the sequence is GEPPPGKPADDAGLV and the mass spectrum shows a peak at 1419.5 Da, the identity is confirmed within instrument tolerance.
For a blend, the same logic applies three times. The chromatogram is separated first. the three compounds elute at different retention times on a reversed-phase column because they have different hydrophobicities. and each eluting peak is then routed into the mass spectrometer for identity confirmation. Three peaks. Three mass matches. Three identity confirmations.
Mass spectrometry works by ionizing a sample. typically by electrospray for compounds. and separating the resulting ions by their mass-to-charge ratio in a magnetic or electric field. The output is a spectrum showing peaks at specific m/z values. For a compound, the observed mass should match its theoretical monoisotopic mass to within about 0.5 Da for a typical instrument, or much tighter for high-resolution systems.
Each of the three GLOW constituents has a distinctive mass fingerprint. BPC-157 at 1419.5 Da is well-separated from TB-500 at 889.0 Da, which is in turn well-separated from GHK-Cu at 402.9 Da. Because the masses do not overlap, there is no ambiguity in the mass spectrum about which peak corresponds to which constituent.
What matters for a reference-standard COA is that the LC-MS section shows the observed mass for each constituent alongside the theoretical mass, with the delta reported. A COA that says only “identity confirmed” without showing the numbers is asking the researcher to trust the process without showing the work.
Purity is a separate question from identity. A vial can contain the correct compound (identity confirmed) but at only 85% purity, with the remaining 15% being truncation products, deletion sequences, oxidation variants, or synthesis byproducts. For research applications where the compound is being used as a reference standard, purity below the mid-90s introduces variables that experimental designs may not account for.
High-performance liquid chromatography pushes a compound mixture through a stationary-phase column under high pressure. Components separate based on their interaction with the column material. for compounds, typically a C18 reversed-phase column where more hydrophobic components are retained longer. As each component elutes off the column, it passes through a UV detector, and the detector signal generates a chromatogram: a plot of absorbance versus retention time.
Purity is calculated as the area under the peak of interest divided by the total area of all peaks in the chromatogram, expressed as a percentage. If BPC-157 elutes at 8.2 minutes and its peak represents 98.5% of the total chromatographic area, the reported HPLC purity for that constituent is 98.5%.
In a GLOW Blend chromatogram, all three constituents appear on the same chromatogram at their respective retention times, plus any impurities associated with each. The purity of each constituent is calculated within its own retention-time window. the peak area for BPC-157 relative to the impurities that co-elute in BPC-157’s window, and the same calculation independently for TB-500 and GHK-Cu.
This is why a single blended purity number for a multi-constituent standard is uninformative. A COA that reports “GLOW Blend ≥98% purity” is technically a statement, but it does not tell the researcher which constituent achieved which purity. The rigorous version reports three purity values. BPC-157 purity, TB-500 purity, GHK-Cu purity. each derived from its own peak-area calculation on the chromatogram.
Image placeholder: Annotated HPLC-UV chromatogram showing three resolved peaks corresponding to BPC-157, TB-500, and GHK-Cu, with per-peak purity percentages labeled.
“Compound purity assessment requires resolution of the target peak from process-related impurities. In multi-component preparations, each component must be independently quantified against its own baseline.”
, Adapted framing consistent with published analytical standards; see also Rivier and Marki (1979), PMID: 258716, on compound chromatography fundamentals.
Here is where blend documentation gets interesting. Purity as measured by HPLC is a chromatographic ratio. the fraction of the eluting material that is the target compound versus everything else that eluted. Net compound content is a different measurement entirely: how much compound, by absolute mass, is actually in the vial?
The distinction matters because lyophilized compounds are not pure compound by mass. A vial labeled “10 mg BPC-157” typically contains 10 mg of net compound, but the total dry mass in the vial is higher because it includes counter-ion (usually trifluoroacetate from HPLC purification), residual moisture, and sometimes small amounts of excipient. If the total mass in the vial is 12 mg and only 10 mg is compound, the net compound content is 83.3%.
For a research reference standard, the researcher weighing out material for a working solution needs to know the mass of compound, not the total mass. If a protocol calls for a 1 mg/mL stock and the researcher weighs out what they think is 10 mg of compound but is actually 8.3 mg of compound plus counter-ion and moisture, the working concentration is off by 17%. In quantitative research, that is a large error.
Net compound content is typically measured by nitrogen analysis (using the compound’s known nitrogen composition to back-calculate mass), by amino acid analysis (hydrolyzing the compound and quantifying the released amino acids against internal standards), or by UV absorption at 205 nm (which quantifies the amide bond). Each method has trade-offs; the important point for a COA reader is that net content is reported alongside purity, not conflated with it.
Synthetic compounds purified by reversed-phase HPLC are almost always isolated as salts with the acid used in the mobile phase. most commonly trifluoroacetate (TFA). The compound’s basic residues (lysine, arginine, histidine, and the N-terminal amine) pair with the trifluoroacetate anion, and the compound is recovered in this salt form after lyophilization.
Different salt forms carry different masses. A compound as its TFA salt has a higher total mass per mole than the same compound as its acetate salt, because trifluoroacetate is a heavier counter-ion than acetate. If two vials of BPC-157 both contain 10 mg of net compound, the TFA-salt vial will have more total mass than the acetate-salt vial.
For GLOW Blend, the counter-ion situation is a little more layered because GHK-Cu already carries a coordinated copper(II) ion as part of its active structure. that copper is not a counter-ion in the salt sense but a stoichiometric ligand to the compound itself. The BPC-157 and TB-500 constituents are typically supplied as TFA salts. A rigorous blend COA declares the salt form for each constituent so the researcher can perform accurate mass accounting.
The remaining two categories on a competent blend COA are appearance and method. Neither is a chemistry result in the same sense that identity, purity, and net content are, but both are documentation the researcher relies on.
Lyophilized compound reference standards are typically described as a white to off-white solid cake or powder. For GLOW Blend, the presence of the copper-compound constituent tints the material. GHK-Cu itself is a deep blue-violet in solution and imparts a blue coloration to the dry material at the loading used in GLOW.
An appearance description on the COA that reads “blue lyophilized solid” or similar is not a red flag. it is consistent with the composition. A description that reads “white powder” for GLOW would actually be inconsistent with the declared composition, because GHK-Cu at 50 mg per 70 mg total should color the material.
The method section describes the analytical instrumentation used to generate the identity and purity data. For a serious COA, this includes the HPLC column type (e.g., C18 reversed-phase), the mobile-phase composition (typically water and acetonitrile with a TFA modifier), the gradient profile, the detection wavelength (commonly 220 nm for amide bond absorption), and the mass spectrometer ionization mode (typically ESI+).
Method documentation is what allows an independent laboratory to reproduce the analysis, which is the whole point of a reference standard.
With the individual categories established, here is how the pieces come together on the actual documentation. The Vitro Labs GLOW Blend COA, prepared per lot by Freedom Diagnostics, presents each category as a labeled section on the certificate.
| Category | What to look for | Why it matters |
|---|---|---|
| Product name and composition | GLOW Blend; BPC-157 10 mg + TB-500 10 mg + GHK-Cu 50 mg | Confirms the three-constituent declaration matches the lot documentation |
| Lot number | Batch-specific alphanumeric identifier | Ties the COA to a specific production batch for traceability |
| Analysis date | Date the analytical work was performed | Establishes the reference point for stability considerations |
| Identity (LC-MS) | Observed vs. theoretical mass for each constituent | Three separate identity confirmations, one per compound |
| Purity (HPLC-UV) | Percentage per constituent based on chromatographic area | Three separate purity values, not one blended average |
| Net compound content | Mass of compound per vial | Distinct from purity; supports accurate mass accounting |
| Appearance | Physical description of the lyophilized material | Provides a visual reference for the received material |
| Method | Instrumentation and conditions | Enables independent reproduction and interpretation |
Every GLOW Blend shipment from Vitro Labs ships with the batch-specific certificate for that lot. The Certificates of Analysis page archives certificates for lot reference and allows researchers to review documentation before adding a lot to laboratory inventory. The GLOW Blend product page links to the current lot documentation directly.
Vitro Labs does not run its own analytical chemistry. The identity and purity work reported on every GLOW Blend COA is performed by Freedom Diagnostics, an independent ISO-certified analytical laboratory based in Franklin, Tennessee. This structural separation between the compound supplier and the analytical laboratory is one of the key trust signals a researcher should look for in reference-standard documentation.
An analytical laboratory that reports on materials manufactured or supplied by an unrelated entity has no commercial incentive to inflate a purity number or overlook an off-spec identity result. The laboratory’s business is analytical accuracy; the supplier’s business is providing material that passes analytical scrutiny. When those two functions are separated, the COA carries more weight than when a supplier’s in-house testing group signs off on the supplier’s own material.
Freedom Diagnostics operates under ISO 17025-consistent quality systems for analytical measurement, uses calibrated LC-MS and HPLC-UV instrumentation, and reports results per lot rather than as a general specification. The laboratory’s contact information appears on the certificate itself, which allows the receiving researcher to verify the COA’s origin if there is any question about authenticity.
Not all blend documentation is created equally. Several patterns show up in the broader research-material market that a rigorous laboratory should recognize as insufficient for a reference-standard procurement.
The most common shortcut. A blend is reported as “≥99% purity” or “≥98% purity” without any per-constituent breakdown. This is either a chromatographic average (which does not exist as a real analytical measurement) or a single-constituent purity treated as representative of the whole. Neither is adequate. A rigorous blend COA reports three purity numbers for a three-compound blend.
A COA that is not tied to a specific lot is a specification sheet, not a certificate of analysis. Specification sheets describe what a material should look like on average across production. Certificates document what a specific batch actually measured. For a research reference standard, only the batch-specific version is useful.
If the COA does not name the laboratory that performed the analysis, or if the laboratory is a subsidiary or in-house group of the supplier itself, the third-party independence claim is weakened. The laboratory name, address, and contact information should appear on the certificate.
Some certificates in the broader market claim analytical categories the underlying laboratory did not actually run. sterility, endotoxin, heavy metals, pyrogenicity. If a category appears on the COA, the researcher should be able to see the corresponding data. If the category is claimed without underlying data, the certificate is not documenting what it claims to document. Vitro Labs’ certificates report the five categories Freedom Diagnostics actually runs. identity, purity, net content, appearance, method. and nothing beyond that.
The final consideration for a research reference standard is lot traceability. Every GLOW Blend vial is tied to a specific manufacturing lot, and the lot number is printed on the vial label as well as on the accompanying COA. If a researcher receives a shipment and needs to verify that the documentation matches the material, the lot number on the vial should match the lot number on the certificate.
Lot traceability enables several downstream research operations. A laboratory that runs a series of experiments over months using GLOW Blend can record the lot number in the laboratory notebook alongside each experiment, so that any subsequent reanalysis or replication attempt uses the same reference material. If a question arises about a specific experimental result, the lot documentation is available to consult.
Vitro Labs archives lot-level documentation and makes it available through the Certificates of Analysis page. This supports the annual review cycle documented in the editorial standards and ties the reference-standard supply chain to a durable documentation trail. The Research Library hosts related sourcing and analytical-methodology articles that provide context for interpreting reference-standard documentation.
For research protocols involving GLOW Blend or any multi-constituent reference standard, the minimum documentation to record alongside experimental data includes: the supplier, the product name, the lot number, the receiving date, the date the vial was first opened or reconstituted, and the storage conditions between uses. This record, paired with the manufacturer’s COA for that lot, creates a complete provenance chain from supplier to experimental result.
GLOW Blend, like all Vitro Labs materials, is supplied as an analytical-grade biochemical reference standard for laboratory research use only. It is intended for in-vitro research, analytical method development, identity verification, and laboratory evaluation by qualified research customers. It is not approved for human or animal consumption, therapeutic use, clinical use, or any form of administration. The compounds discussed in this article. BPC-157, TB-500, and GHK-Cu. have preclinical literature histories but are not FDA-approved for any human indication.
Researchers evaluating reference standards should verify that their institutional protocols, applicable regulations, and analytical workflows are consistent with the material’s declared scope before adding a lot to laboratory inventory.
A GLOW Blend COA documents five categories: identity (confirmed by LC-MS for each of the three constituents. BPC-157, TB-500, and GHK-Cu), purity (measured by HPLC-UV separately for each constituent), net compound content (the actual mass of compound in the vial), appearance (physical description of the lyophilized material), and method (the analytical instrumentation and conditions used). Vitro Labs certificates are issued per lot by Freedom Diagnostics, an independent ISO-certified analytical laboratory. Categories not documented on the certificate. such as sterility, endotoxin, or heavy metals. are not represented as tested. For laboratory research use only.
A single purity number for a multi-constituent blend does not tell a researcher which constituent achieved which purity. In a three-compound blend, one constituent could be 99% pure while another is 92%, and an averaged number would obscure the difference. Because each compound has its own retention time on a reversed-phase HPLC column and its own impurity profile, the rigorous analytical approach is to report per-constituent purity. three values for GLOW Blend, one for each of BPC-157, TB-500, and GHK-Cu. This lets a research laboratory evaluate whether the reference standard meets purity thresholds relevant to their specific investigation.
Identity is confirmed by liquid chromatography-mass spectrometry (LC-MS) for each of the three constituents independently. The HPLC step separates the three compounds by retention time on a reversed-phase column, and the mass spectrometer measures the mass-to-charge ratio of each eluting peak. The observed monoisotopic mass for each constituent is compared to its theoretical mass. approximately 1419.5 Da for BPC-157, 889.0 Da for TB-500, and 402.9 Da for GHK-Cu. A match within instrument tolerance confirms identity for that constituent. Freedom Diagnostics performs the analysis and reports the observed and theoretical values on the certificate.
HPLC purity is a chromatographic ratio. the percentage of eluting material that is the target compound relative to co-eluting impurities. Net compound content is a different measurement: the absolute mass of compound in the vial, distinct from counter-ion, moisture, or excipient mass. A vial can be 98% pure by HPLC (chromatographic quality is high) and simultaneously have a lower net compound content by mass (because trifluoroacetate counter-ion and residual moisture contribute to total mass). A rigorous COA reports both values so researchers can perform accurate mass accounting for working solutions.
Freedom Diagnostics is an independent ISO-certified analytical laboratory based in Franklin, Tennessee. The structural separation between the compound supplier (Vitro Labs) and the analytical laboratory (Freedom Diagnostics) is a trust signal: the laboratory has no commercial incentive to overlook off-spec identity or inflate a purity number, because its business is analytical accuracy rather than material supply. Freedom Diagnostics performs LC-MS and HPLC-UV analysis per lot, and its laboratory contact information appears on every certificate.
Four common red flags: (1) a single averaged purity number for a multi-constituent blend rather than per-constituent values; (2) a certificate without a lot number, which makes it a general specification rather than a batch-specific document; (3) no identification of the analytical laboratory that performed the work, weakening third-party independence; and (4) claimed analytical categories. sterility, endotoxin, heavy metals. without underlying data on the certificate. A rigorous reference-standard COA reports only categories that were actually measured and provides the corresponding data for each.
